Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More


Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Dogs, Chickens, and Turtles…Oh My! Is Your Pet a Reservoir for Salmonella?

A third of animal acquired illnesses are attributed to Salmonella infection.

Have you ever wondered if your pet could make you sick? Did you know that kissing your pets or letting them share your food can lead to a serious or even life-threatening gastrointestinal infection? Of the 3.2 million enteric illnesses acquired annually in the U.S., 14% are caused by animal contact and a third are due to Salmonella species…”

Continue Reading…

We Are Luminex

We Are Luminex


At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter

Visit booth 722 to learn more about our role in the fight against #Zika. #IDWeek2016
h J R
From microbiology to photography, get to know Paige Huggins, Field Applications Coordinator:…
h J R
Register for @LabRoots 7th annual Clinical Diagnostics & Research online conference, which takes place Nov. 2-3:
h J R

Latest News

October 11
Luminex Corporation Third Quarter Earnings Release Scheduled for October 31, 2016

August 8
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay

August 3
Luminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus

July 28
Luminex Corporation Reports Second Quarter 2016 Results

July 20
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time

July 8
Luminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016


SCASM Annual Meeting
October 26-29
La Jolla, CA

October 26-30
New Orleans, LA

UNY-AACC & CNY-CLMA Annual Conference
November 10-11
Verona, NY

AMP Annual Meeting
November 10-12
Charlotte, NC

xMAP® Connect
November 16-17
Amsterdam, NL